Things have been unexpectedly gloomy for private equity exits this year, despite earlier hopes for a resurgence in the first half. But there are signs of optimism creeping back in.

Kasia Karapuda, CFA, is a recipient of the Women in Investment Management Recognition. Before she assumed her current role of ...

Institutional Investor was proud to recognize leaders within the allocator community for their outstanding contributions to ...

This year, Institutional Investor is honoring 10 Rising Stars in the hedge fund industry. The talented professionals in this elite group are recognized for their outstanding contributions and ...

Stan Ra, CIO of Seattle Children’s, has been the driving force behind the hospital’s investment strategy since 2016. As the organization’s first dedicated chief investment officer, Ra built ...

Sylebra Capital surged on a few contrarian bets, though it remains slightly down for the year. Lone Pine, D1, and Maverick all extended their strong 2025 runs, while others like Tiger Global and ...

Fidelity’s Erika Murphy discusses some key considerations for endowments and foundations looking to align their portfolio investments with their mission. To support nonprofits’ mission ...

The tech-focused firm, led by Alex Sacerdote, halved losses in two hedge fund share classes and generated double-digit returns in its long-only strategies. Its flagship hybrid fund — which ...

Kasia Karapuda, CFA, is a recipient of the Women in Investment Management Recognition. Before she assumed her current role of Associate Director of Investments, Kasia first joined the $1.4 billion ...

Most biopharma and life sciences hedge funds continued to struggle in May in what is shaping up to be one of the worst years in recent memory for the strategy. Many funds are down by double-digit ...

Each of these indicators mentioned bear watching, however. If higher-than-average market volatility and more consumer stress were to continue, history suggests they could exacerbate stressed debt ...

An evening of seven awards, exclusively for — and chosen by — asset allocators. Join us for the most elite event in institutional investing.